Psychiatry Under the Influence

Psychiatry Under the Influence examines how pharmaceutical industry funding has shaped psychiatric diagnoses, research, and clinical care in the United States. Authors Robert Whitaker and Lisa Cosgrove present documentation of financial relationships between drug companies and psychiatric institutions, researchers, and practitioners. The book traces key developments in psychiatry from the 1980s forward, focusing on how the DSM diagnostic manual evolved and how drug trials were conducted and reported. Through case studies and data analysis, it details specific instances where commercial interests intersected with medical decision-making. The authors investigate the impact of industry influence on psychiatric education, professional associations, clinical practice guidelines, and public health messaging. They outline both the direct financial ties and the subtle institutional pressures that have affected the field. At its core, this work raises fundamental questions about evidence-based medicine and the challenges of maintaining scientific objectivity in a commercialized healthcare environment. The analysis contributes to broader discussions about reform in psychiatric practice and medical institutions.

Readers describe this as an detailed exposé of conflicts of interest in psychiatry, particularly financial ties between pharmaceutical companies and the psychiatric profession. Many note it presents clear evidence and documentation rather than just criticism. Readers appreciated: - Clear breakdown of how money influences diagnostic criteria - Specific examples and case studies - Focus on systemic issues rather than individual blame - Accessible writing style for non-medical readers Common criticisms: - Some sections become repetitive - Could have offered more solutions/alternatives - A few readers found the tone too accusatory Ratings: Goodreads: 4.21/5 (236 ratings) Amazon: 4.5/5 (98 ratings) From readers: "Documents the corruption without resorting to conspiracy theories" - Goodreads reviewer "Important but depressing read about psychiatric industry practices" - Amazon reviewer "Sometimes gets bogged down in details but the research is solid" - Goodreads reviewer

Anatomy of an Epidemic by Robert Whitaker This investigation traces the rise of psychiatric medication use in America and examines the connection between the pharmaceutical industry's influence and the surge in mental health disability rates.

Unhinged by Daniel Carlat A practicing psychiatrist details his firsthand experiences with pharmaceutical company marketing and its impact on psychiatric diagnosis and treatment.

Our Daily Meds by Melody Petersen This investigation reveals how pharmaceutical marketing practices influence medical research, doctor prescribing habits, and patient care in the United States healthcare system.

Mad in America by Robert Whitaker The book traces the history of schizophrenia treatment in America and documents the influence of pharmaceutical companies on treatment protocols.

The Emperor's New Drugs by Irving Kirsch Through analysis of clinical trial data, this work examines the effectiveness of antidepressant medications and the role of the placebo effect in psychiatric treatment.

🔬 The book exposes how 69% of the panel members who created the DSM-5 (psychiatry's diagnostic manual) had financial ties to pharmaceutical companies. 💊 Robert Whitaker previously won the George Polk Award for his investigation into psychiatric research conducted on homeless people with mental illness. 📚 The book demonstrates how the chemical imbalance theory of depression, widely promoted for decades, lacks substantial scientific evidence despite its popular acceptance. 🏥 The authors reveal that the number of Americans receiving disability payments for mental illness has increased nearly six-fold since 1987, raising questions about current treatment approaches. 🔍 The book traces how psychiatric diagnoses have expanded from 106 disorders in DSM-I (1952) to 297 disorders in DSM-5 (2013), leading to what critics call "diagnostic inflation."